39plus is a not-for-profit organisation dedicated to providing a new approach to delivering quality care to older people across the 39 postcode region. 39plus offers a range of support services for older people, people with disabilities and their carers.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHYLAGEN, A BIOTECH COMPANY LAUNCHES PHYLAGEN SURFACE™ SARS-COV-2 TEST KIT TO DETECT THE VIRUS

Phylagen | July 31, 2020

news image

Phylagen, an award-winning biotech company specializing in decoding the environmental microbiome for indoor safety, today announced the national availability of its Phylagen Surface™ SARS-CoV-2 (COVID-19) test kit. Designed to be used by anyone on any surface, Phylagen Surface™ provides an early indication of outbreaks in shared spaces including nursing homes, schools, hospitals, restaurants, offices and retail shops."Surface testing can help curb the spread of COVID-19 bu...

Read More

MedTech

OCHRE BIO ENTERS INTO CHARITABLE DONATION AGREEMENT WITH BRITISH LIVER TRUST

Ochre Bio | December 15, 2021

news image

Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, announced to have entered into a Charitable Donation Agreement with the British Liver Trust in support of improving awareness for liver health. “On our path to develop next-generation RNA medicines with the potential to improve the lives of patients in need of a liver transplant, we are grateful to have access to discarded donor livers, allowing us to develop therapeutics that are safe and effe...

Read More

Industrial Impact

ANTHEIA AND GINKGO BIOWORKS ANNOUNCE PARTNERSHIP TO ACCELERATE PRODUCTION OF ESSENTIAL MEDICINES USING SYNTHETIC BIOLOGY

Antheia | August 13, 2021

news image

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the development and production of essential medicines. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ: SRNG), serves customers across industries seeking to develop new and better products. Antheia plans to leverage Ginkgo...

Read More

MedTech, Industrial Impact

CENTOGENE LAUNCHES NEW CENTOGENOME®, WORLD’S MOST COMPREHENSIVE WHOLE GENOME SEQUENCING SOLUTION FOR DIAGNOSIS OF RARE AND NEURODEGENERATIVE DISEASES

Globenewswire | April 13, 2023

news image

Centogene N.V. the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the launch of NEW CentoGenome®, an enhanced Next Generation Sequencing (NGS)-based assay. Healthcare professionals can leverage NEW CentoGenome to provide more comprehensive diagnostic information, which could accelerate access to potential treatment options. Serving as a first-line test, NEW CentoGenome is the most comprehensive commercially avai...

Read More
news image

PHYLAGEN, A BIOTECH COMPANY LAUNCHES PHYLAGEN SURFACE™ SARS-COV-2 TEST KIT TO DETECT THE VIRUS

Phylagen | July 31, 2020

Phylagen, an award-winning biotech company specializing in decoding the environmental microbiome for indoor safety, today announced the national availability of its Phylagen Surface™ SARS-CoV-2 (COVID-19) test kit. Designed to be used by anyone on any surface, Phylagen Surface™ provides an early indication of outbreaks in shared spaces including nursing homes, schools, hospitals, restaurants, offices and retail shops."Surface testing can help curb the spread of COVID-19 bu...

Read More
news image

MedTech

OCHRE BIO ENTERS INTO CHARITABLE DONATION AGREEMENT WITH BRITISH LIVER TRUST

Ochre Bio | December 15, 2021

Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, announced to have entered into a Charitable Donation Agreement with the British Liver Trust in support of improving awareness for liver health. “On our path to develop next-generation RNA medicines with the potential to improve the lives of patients in need of a liver transplant, we are grateful to have access to discarded donor livers, allowing us to develop therapeutics that are safe and effe...

Read More
news image

Industrial Impact

ANTHEIA AND GINKGO BIOWORKS ANNOUNCE PARTNERSHIP TO ACCELERATE PRODUCTION OF ESSENTIAL MEDICINES USING SYNTHETIC BIOLOGY

Antheia | August 13, 2021

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the development and production of essential medicines. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ: SRNG), serves customers across industries seeking to develop new and better products. Antheia plans to leverage Ginkgo...

Read More
news image

MedTech, Industrial Impact

CENTOGENE LAUNCHES NEW CENTOGENOME®, WORLD’S MOST COMPREHENSIVE WHOLE GENOME SEQUENCING SOLUTION FOR DIAGNOSIS OF RARE AND NEURODEGENERATIVE DISEASES

Globenewswire | April 13, 2023

Centogene N.V. the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the launch of NEW CentoGenome®, an enhanced Next Generation Sequencing (NGS)-based assay. Healthcare professionals can leverage NEW CentoGenome to provide more comprehensive diagnostic information, which could accelerate access to potential treatment options. Serving as a first-line test, NEW CentoGenome is the most comprehensive commercially avai...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us